Divisione di Nefrologia, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Via G. Moscati 31, 00168, Rome, Italy.
Nephrology Division, NYU Langone Medical Center, New York, NY, USA.
J Nephrol. 2018 Aug;31(4):537-542. doi: 10.1007/s40620-018-0480-8. Epub 2018 Feb 21.
Medullary sponge kidney (MSK) is a cause of nephrocalcinosis, associated with hematuria, renal colic, pyelonephritis. There are rare and atypical MSK cases characterized by chronic severe pain (CP), whose features are unknown, in particular the relationship with the stone disease activity. This study analyzes a cohort of MSK-CP patients belonging to three North-America self-support Facebook groups. Patients had to self-administer an on-line questionnaire (on intensity, progression and MSK-associated conditions, stone-related disease, pain features, drug use), the Brief Pain Inventory, the Fatigue Severity Score, and Wisconsin Quality of Life (WQL) in stone formers questionnaires. Ninety-two patients with a diagnosis of MSK joined our survey. Stone rate was very high (3.1 stones per patient-year, < 15% of patients had ≤ 1 stone per year). Most patients had repeated hospitalizations for stones symptoms (p < 0.001) or pain (p < 0.005). 71% of participants referred a daily pain that interfered strongly with everyday life and quality of life (WQL mean value 29.4). 69% used pain medications daily (70% opioids). In most cases, pain was associated with stone passage, while 15% referred a sine materia pain. We showed how MSK-CP symptoms affect very negatively on the quality of life of these patients. They also have a definite risk of progressing to end-stage kidney disease. Generally, CP seems to be associated with an exceptionally high lithogenic activity, suggesting that a better and earlier metabolic treatment for stone prevention should be the first approach in these patients before mini-invasive treatments to prevent pain.
海绵肾(MSK)是导致肾钙质沉着症的原因之一,常伴有血尿、肾绞痛和肾盂肾炎。也有罕见且不典型的 MSK 病例表现为慢性严重疼痛(CP),其特征尚不清楚,特别是与结石疾病活动的关系。本研究分析了属于三个北美自助 Facebook 群组的 MSK-CP 患者队列。患者必须自行在线填写问卷(关于强度、进展和 MSK 相关情况、结石相关疾病、疼痛特征、药物使用情况)、简明疼痛量表(Brief Pain Inventory)、疲劳严重程度评分(Fatigue Severity Score)和结石形成者威斯康星生活质量问卷(Wisconsin Quality of Life Questionnaire,WQL)。92 名 MSK 诊断患者参加了我们的调查。结石发生率非常高(每位患者每年 3.1 颗结石,<15%的患者每年结石数≤1 颗)。大多数患者因结石症状(p<0.001)或疼痛(p<0.005)反复住院。71%的参与者每天都有强烈影响日常生活和生活质量的疼痛(WQL 平均值为 29.4)。69%的人每天使用止痛药(70%是阿片类药物)。在大多数情况下,疼痛与结石排出有关,而 15%的人则出现无结石性疼痛。我们展示了 MSK-CP 症状如何对这些患者的生活质量产生非常不利的影响。他们也有进展为终末期肾病的明确风险。一般来说,CP 似乎与异常高的成石活性有关,这表明对于这些患者,在进行微创治疗以预防疼痛之前,应首先采取更好和更早的代谢治疗来预防结石。